Hangzhou Jiuyuan Gene Engineering Co., Ltd.

Hangzhou Jiuyuan Gene Engineering Co., Ltd. (hereinafter called “Jiuyuan” or “the company”) is a top-biotech joint venture specializing in the research, development, manufacture and marketing of pharmaceuticals based on gene engineering and biochemical technology since 1993.

Jiuyuan has marketing agencies in all provinces of China. It has gene engineering workshops, injection workshops, pharmaceutical API workshops and other sections including quality management department, warehouse, engineering department etc., all of which are built according to GMP requirements. Jiuyuan is equipped with advanced production and analysis instruments like chromatography system, HPLC and capillary electrophoresis.

As a high-tech enterprise, Jiuyuan regards excellent talents as the base of the company all the time. It has established a professional team with rational education structure and abundant experience in research, production, quality, marketing and administration. At present, the company has 521 employees, in which, there are 412 technicians, at 79% of the total amount; 72 people with senior or middle professional titles, at 14%; 120 people with junior professional titles, at 23%. In addition, the company has 10 licensed pharmacists.

Jiuyuan always devotes in the research and development of bio-pharmaceuticals, in order to provide the society with high quality & effectiveness products, and render services to human’s health.

Products: rhG-CSF(Filgrastim), Enoxaparin sodium API and injection, rhIL-11(Oprelvekin) bulk and injection, Palonosetron hydrochloride API and injection. rhBMP-2(Recombinant Human Bone Morphogenetic Protein-2), Liraglutide, Fulvestrant, PegFilgrastim, Fosaprepitant dimeglumme, Semaglutide, Dulaglutide, Ranibizumab, Insulin Detemir, Rivaroxaban, Insulin degludec, Insulin Aspart, Avatrombopag malemate, Daratumumab